MedTrace Logo

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

NCT07420751 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2026-04-28

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate the usability of auto-captioning glasses for adults diagnosed with NF2-related schwannomatosis and loss of hearing. The primary objective of the study is to determine the feasibility and acceptability of auto-captioning glasses in this population.

Participants will be asked to:

* Use the glasses at their discretion for 12 weeks
* Report their feedback at 3 and 12 week timepoints via online surveys and remote qualitative interviews

Conditions

  • NF2-related Schwannomatosis

Interventions

DEVICE

Auto-captioning Glasses

Augmented reality glasses that overlay real time captioning on see-through lenses, allowing users to read what is being said out loud.

Sponsors & Collaborators

Principal Investigators

  • Vanessa Merker, PhD · Massachusetts General Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-19
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07420751 on ClinicalTrials.gov